As the shift toward value-based payment models continues, there are new ways for pharmacists to improve patient care in medical homes, accountable care organizations, and other innovative care models.

They say that necessity is the mother of invention—an adage that has been borne out in the pandemic. While the hospital-at-home model was not invented during the pandemic, COVID-19 has prompted health care facilities to launch programs that may have been in the works for years.

Sonya Collins

You are exhausted and, frankly, you—like so many other health care providers right now—have no more energy to care. Could this be “empathy fatigue?”

Loren Bonner

Opioid use, while appropriate in many cases, may be associated with increased morbidity and mortality from infection, suggests a study published in Pharmacotherapy from June 2021.

Joey Sweeney, PharmD, BCPS

As a beneficial treatment for COVID-19, remdesivir (Veklury–Gilead Sciences) was rapidly introduced to market through FDA’s emergency use authorization in May 2020 with little known about its adverse effects.

Corey Diamond, PharmD